First Rounders: Grace Colón

I ended up spending the summer hiking in the Pyrenees and camping out and almost not coming back.
First Rounders: Grace Colón
Like

Share this post

Choose a social network to share with, or copy the shortened URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

The most recent guest on First Rounders is Grace Colón, president and CEO of InCarda Therapeutics. She did her graduate work at MIT, where she was mentored by Greg Stephanopoulos and Anthony Sinskey, and then went to work at McKinsey & Co. That began her career path toward biotech, including stints at Affymetrix (later bought by Thermo Fisher), and Gilead Sciences (currently doing its part against covid19).

She also has experience in venture capital, having been with New Science Ventures. The podcast can be found here.

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Subscribe to the Topic

Biotechnology
Life Sciences > Biological Sciences > Biotechnology